EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE was reported 11421 times

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHARYNGEAL CHLAMYDIA INFECTION 3 0.4286
1 BONE DEMINERALISATION 240 0.2266
2 BONE LOSS 2649 0.1760
3 HIV ANTIBODY POSITIVE 9 0.1667
4 SKELETAL INJURY 1632 0.1577
5 BONE DENSITY DECREASED 4869 0.1552
6 MULTIPLE FRACTURES 2442 0.1485
7 TOOTH LOSS 2330 0.1123
8 OSTEOPENIA 1516 0.0998
9 BONE DENSITY ABNORMAL 337 0.0901
10 POLYMICROGYRIA 4 0.0889
11 TOOTH INJURY 379 0.0872
12 PROTEIN TOTAL ABNORMAL 111 0.0853
13 OSTEONECROSIS 2620 0.0797
14 CEREBRAL DYSGENESIS 4 0.0667
15 MALIGNANT ANORECTAL NEOPLASM 5 0.0667
16 ANHEDONIA 1701 0.0647
17 RENAL INJURY 1886 0.0634
18 DEGENERATIVE BONE DISEASE 26 0.0587
19 OSTEOPOROSIS 2283 0.0554
20 SYPHILIS 36 0.0495
21 VIRAL LOAD 7 0.0405
22 FANCONI SYNDROME ACQUIRED 70 0.0398
23 ECONOMIC PROBLEM 589 0.0388
24 GLOMERULAR FILTRATION RATE ABNORMAL 54 0.0381
25 CHRONIC KIDNEY DISEASE 2890 0.0380
26 VITAMIN D DEFICIENCY 355 0.0364
27 BLOOD HIV RNA INCREASED 66 0.0364
28 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 4 0.0360
29 BETA 2 MICROGLOBULIN URINE INCREASED 5 0.0350
30 OSTEOMALACIA 54 0.0349
31 NEPHROPATHY 291 0.0311
32 TEETH BRITTLE 31 0.0296
33 CONGENITAL SKIN DIMPLES 7 0.0290
34 HIV TEST POSITIVE 19 0.0287
35 HIV VIRAEMIA 6 0.0286
36 ALCOHOLIC SEIZURE 2 0.0270
37 CONGENITAL CEREBRAL CYST 3 0.0268
38 FEAR-RELATED AVOIDANCE OF ACTIVITIES 4 0.0263
39 CONGENITAL HYDROCEPHALUS 13 0.0256
40 ACUTE HIV INFECTION 6 0.0243
41 GLOMERULAR FILTRATION RATE INCREASED 20 0.0242
42 CD4 LYMPHOCYTES ABNORMAL 5 0.0238
43 VIRAL LOAD ABNORMAL 4 0.0229
44 PROTEIN TOTAL INCREASED 58 0.0218
45 AVULSION FRACTURE 6 0.0209
46 VIRAL LOAD DECREASED 3 0.0205
47 TOOTH DEVELOPMENT DISORDER 3 0.0204
48 FRACTURE 342 0.0180
49 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 6 0.0179
50 HAND FRACTURE 125 0.0176
51 SOCIOECONOMIC PRECARITY 3 0.0174
52 RENAL FAILURE 2267 0.0171
53 DENTAL NECROSIS 5 0.0170
54 BONE METABOLISM DISORDER 5 0.0166
55 EMOTIONAL DISTRESS 1925 0.0159
56 ULNA FRACTURE 15 0.0151
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16 0.0151
58 FIBULA FRACTURE 43 0.0149
59 FOOT FRACTURE 279 0.0147
60 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 3 0.0145
61 RENAL TUBULAR DYSFUNCTION 8 0.0142
62 PELVIC FLOOR DYSFUNCTION 3 0.0142
63 TOOTH FRACTURE 151 0.0137
64 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 68 0.0136
65 OSTEOPOROTIC FRACTURE 26 0.0136
66 RADIUS FRACTURE 32 0.0133
67 TIBIA FRACTURE 62 0.0132
68 SITTING DISABILITY 8 0.0130
69 FAT REDISTRIBUTION 3 0.0129
70 CD4 LYMPHOCYTES INCREASED 3 0.0129
71 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 3 0.0127
72 ACUTE HEPATITIS B 4 0.0120
73 GENOTYPE DRUG RESISTANCE TEST POSITIVE 12 0.0117
74 WRIST FRACTURE 140 0.0117
75 VARICOCELE 3 0.0114
76 CONGENITAL EYE DISORDER 3 0.0112
77 GONORRHOEA 3 0.0111
78 HEPATITIS A 9 0.0106
79 GASTROINTESTINAL TUBE INSERTION 26 0.0104
80 SHOULDER FRACTURE 17 0.0104
81 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 9 0.0103
82 T-LYMPHOCYTE COUNT DECREASED 7 0.0103
83 ANKLE FRACTURE 158 0.0102
84 POOR DENTAL CONDITION 3 0.0101
85 ALCOHOLIC 2 0.0101
86 HIV INFECTION 30 0.0099
87 CONGENITAL CHOROID PLEXUS CYST 3 0.0098
88 CLAVICLE FRACTURE 37 0.0097
89 ACQUIRED IMMUNODEFICIENCY SYNDROME 5 0.0096
90 SCAPULA FRACTURE 5 0.0096
91 SKULL MALFORMATION 6 0.0093
92 BLOOD CREATININE INCREASED 596 0.0091
93 VIRAL LOAD INCREASED 35 0.0090
94 INTERVERTEBRAL DISC DEGENERATION 82 0.0089
95 ANENCEPHALY 5 0.0088
96 JAW FRACTURE 17 0.0079
97 GASTROSTOMY 12 0.0077
98 PATELLA FRACTURE 18 0.0077
99 RIB FRACTURE 155 0.0075
100 ALBUMINURIA 4 0.0075
101 RENAL IMPAIRMENT 627 0.0075
102 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
103 BONE DISORDER 132 0.0072
104 SPINA BIFIDA 15 0.0072
105 FOREARM FRACTURE 5 0.0072
106 MALARIA 5 0.0071
107 GLOMERULAR FILTRATION RATE DECREASED 87 0.0071
108 ATYPICAL MYCOBACTERIAL INFECTION 10 0.0071
109 SPINAL OSTEOARTHRITIS 62 0.0071
110 PRODUCT BLISTER PACKAGING ISSUE 7 0.0067
111 END STAGE RENAL DISEASE 122 0.0067
112 LIPODYSTROPHY ACQUIRED 14 0.0066
113 BONE INFARCTION 3 0.0066
114 HUMERUS FRACTURE 31 0.0064
115 PROTEINURIA 121 0.0064
116 HYPERPARATHYROIDISM 13 0.0063
117 SPINAL COMPRESSION FRACTURE 52 0.0063
118 ANXIETY 1786 0.0063
119 INTERVERTEBRAL DISC SPACE NARROWING 5 0.0062
120 FAT TISSUE INCREASED 9 0.0062
121 HIP ARTHROPLASTY 95 0.0062
122 BLOOD CREATINE INCREASED 27 0.0061
123 CD4 LYMPHOCYTES DECREASED 13 0.0061
124 BLOOD CREATININE ABNORMAL 21 0.0061
125 OSTEOCHONDROSIS 7 0.0060
126 PROTEIN URINE PRESENT 30 0.0060
127 FRACTURED SACRUM 7 0.0056
128 AMNIOTIC CAVITY INFECTION 4 0.0055
129 FRACTURED COCCYX 7 0.0055
130 NEURAL TUBE DEFECT 4 0.0055
131 CEREBRAL TOXOPLASMOSIS 5 0.0054
132 ACETABULUM FRACTURE 2 0.0053
133 OEDEMATOUS PANCREATITIS 3 0.0053
134 SPINAL STENOSIS 22 0.0053
135 PARTNER STRESS 5 0.0052
136 OSTEOGENESIS IMPERFECTA 3 0.0051
137 PATHOLOGICAL FRACTURE 26 0.0051
138 DECREASED ACTIVITY 55 0.0051
139 LIMB MALFORMATION 4 0.0051
140 QUALITY OF LIFE DECREASED 68 0.0051
141 TINEA PEDIS 8 0.0050
142 DENTAL CARIES 55 0.0050
143 LOWER LIMB FRACTURE 95 0.0049
144 UPPER LIMB FRACTURE 96 0.0048
145 LUMBAR SPINAL STENOSIS 14 0.0048
146 URETEROLITHIASIS 5 0.0048
147 THORACIC VERTEBRAL FRACTURE 14 0.0047
148 CRANIOFACIAL FRACTURE 4 0.0047
149 CERVICAL SPINAL STENOSIS 8 0.0046
150 NEUROPATHIC ARTHROPATHY 3 0.0046
151 RENAL TUBULAR ACIDOSIS 10 0.0046
152 OSTEOARTHRITIS 194 0.0046
153 HIP FRACTURE 146 0.0045
154 SINGLE FUNCTIONAL KIDNEY 3 0.0045
155 RENAL CYST 36 0.0045
156 BONE DEFORMITY 3 0.0045
157 DYSLIPIDAEMIA 22 0.0043
158 LUMBAR RADICULOPATHY 5 0.0043
159 ACUTE KIDNEY INJURY 648 0.0042
160 PRODUCT PACKAGING DIFFICULT TO OPEN 11 0.0042
161 FACIAL BONES FRACTURE 15 0.0042
162 LIPIDS ABNORMAL 3 0.0041
163 BLOOD BILIRUBIN UNCONJUGATED INCREASED 3 0.0041
164 COMPRESSION FRACTURE 22 0.0041
165 CERVICAL VERTEBRAL FRACTURE 14 0.0041
166 CALCIUM DEFICIENCY 5 0.0039
167 HYPERTENSIVE NEPHROPATHY 4 0.0037
168 GLYCOSURIA 5 0.0037
169 SPINAL FRACTURE 74 0.0037
170 MITOCHONDRIAL TOXICITY 3 0.0037
171 HYPERURICAEMIA 15 0.0036
172 CLEFT LIP AND PALATE 4 0.0036
173 RENAL TUBULAR DISORDER 10 0.0036
174 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
175 FANCONI SYNDROME 5 0.0035
176 ENZYME LEVEL INCREASED 3 0.0035
177 SPONDYLOLISTHESIS 6 0.0035
178 RENAL MASS 7 0.0034
179 ANOGENITAL WARTS 3 0.0034
180 JOINT ARTHROPLASTY 6 0.0033
181 SHOULDER ARTHROPLASTY 9 0.0033
182 PAIN 2017 0.0033
183 RENAL ATROPHY 4 0.0032
184 BONE CYST 3 0.0032
185 HYPERAESTHESIA TEETH 4 0.0032
186 LIPOATROPHY 3 0.0032
187 HEPATITIS B REACTIVATION 10 0.0031
188 PYELOCALIECTASIS 3 0.0031
189 PRODUCT DISPENSING ERROR 67 0.0031
190 LUMBAR VERTEBRAL FRACTURE 14 0.0031
191 TOOTH EXTRACTION 38 0.0031
192 MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0030
193 CHONDROPATHY 8 0.0030
194 FIBROSIS 9 0.0029
195 WAIST CIRCUMFERENCE INCREASED 3 0.0029
196 SPINAL COLUMN INJURY 6 0.0027
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 127 0.0026
198 THYROTOXIC CRISIS 3 0.0026
199 PREMATURE SEPARATION OF PLACENTA 4 0.0026
200 PATHOGEN RESISTANCE 23 0.0025
201 RENAL TRANSPLANT 9 0.0025
202 HEPATITIS B 15 0.0025
203 ABDOMINAL SYMPTOM 2 0.0025
204 LIPIDS INCREASED 5 0.0025
205 SKULL FRACTURE 4 0.0025
206 PELVIC FRACTURE 19 0.0024
207 STERNAL FRACTURE 3 0.0024
208 SEBORRHOEIC DERMATITIS 4 0.0024
209 STRESS FRACTURE 13 0.0024
210 POST-TRAUMATIC STRESS DISORDER 16 0.0024
211 RENAL PAIN 25 0.0024
212 FEMUR FRACTURE 73 0.0024
213 URINE ANALYSIS ABNORMAL 7 0.0023
214 FEMORAL NECK FRACTURE 12 0.0023
215 FOETAL DEATH 12 0.0023
216 ADJUSTMENT DISORDER 3 0.0023
217 ARTERIAL STENOSIS 2 0.0023
218 RADICULOPATHY 6 0.0023
219 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
220 EXERCISE TOLERANCE DECREASED 13 0.0023
221 BODY MASS INDEX INCREASED 3 0.0022
222 CYTOMEGALOVIRUS COLITIS 5 0.0022
223 VIRAEMIA 3 0.0022
224 ADENOCARCINOMA GASTRIC 2 0.0022
225 RENAL FUNCTION TEST ABNORMAL 10 0.0022
226 CARDIOVERSION 3 0.0021
227 PRODUCT STORAGE ERROR 188 0.0021
228 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
229 ENDOTRACHEAL INTUBATION 6 0.0021
230 PERIODONTAL DISEASE 3 0.0021
231 PANCREATITIS CHRONIC 5 0.0021
232 PLANTAR FASCIITIS 7 0.0021
233 ANAL CANCER 2 0.0021
234 DYSSTASIA 59 0.0020
235 IMPETIGO 3 0.0020
236 HYPERPARATHYROIDISM SECONDARY 5 0.0020
237 LIBIDO INCREASED 4 0.0020
238 NEPHROLITHIASIS 89 0.0019
239 VIRAL MUTATION IDENTIFIED 7 0.0019
240 TESTICULAR PAIN 6 0.0019
241 PRODUCT DISPENSING ISSUE 8 0.0019
242 BLOOD TRIGLYCERIDES INCREASED 33 0.0019
243 STILLBIRTH 9 0.0019
244 HYPERPHOSPHATAEMIA 4 0.0019
245 FACET JOINT SYNDROME 6 0.0018
246 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
247 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
248 RENAL COLIC 4 0.0018
249 TRIGEMINAL NEURALGIA 7 0.0017
250 RENAL DISORDER 81 0.0017
251 RENAL TUBULAR NECROSIS 17 0.0017
252 KIDNEY FIBROSIS 3 0.0017
253 PRODUCT CONTAINER SEAL ISSUE 3 0.0017
254 DRUG RESISTANCE 44 0.0017
255 KYPHOSIS 3 0.0017
256 PRE-ECLAMPSIA 8 0.0017
257 VIROLOGIC FAILURE 9 0.0017
258 HEPATITIS C 20 0.0017
259 RENAL CELL CARCINOMA 8 0.0016
260 PNEUMONIA KLEBSIELLA 3 0.0016
261 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
262 INTENTIONAL DOSE OMISSION 46 0.0016
263 HYPERACUSIS 6 0.0016
264 SACROILIITIS 3 0.0016
265 MECHANICAL VENTILATION 3 0.0016
266 GINGIVAL RECESSION 3 0.0016
267 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
268 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
269 EXOSTOSIS 14 0.0015
270 EXFOLIATIVE RASH 4 0.0015
271 BLOOD LACTIC ACID INCREASED 8 0.0015
272 GENE MUTATION 3 0.0015
273 FOETAL GROWTH RESTRICTION 9 0.0015
274 GESTATIONAL DIABETES 7 0.0015
275 PSYCHOTIC SYMPTOM 3 0.0015
276 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
277 MICROCYTIC ANAEMIA 3 0.0014
278 ATRIAL SEPTAL DEFECT 12 0.0014
279 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
280 DEPRESSIVE SYMPTOM 5 0.0014
281 RENAL NEOPLASM 3 0.0014
282 GASTRIC BYPASS 3 0.0014
283 LIVER TRANSPLANT 5 0.0014
284 HYPERTRIGLYCERIDAEMIA 8 0.0014
285 DEPRESSION 307 0.0013
286 RHINITIS ALLERGIC 6 0.0013
287 MALABSORPTION 7 0.0013
288 BONE PAIN 78 0.0013
289 PRODUCT LABEL ISSUE 9 0.0013
290 EMERGENCY CARE 4 0.0013
291 POLLAKIURIA 55 0.0013
292 ORAL PRURITUS 3 0.0013
293 LYMPHOMA 20 0.0013
294 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
295 SCOLIOSIS 8 0.0013
296 NECK SURGERY 3 0.0013
297 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
298 BLOOD CREATININE DECREASED 4 0.0013
299 BRAIN FOG 20 0.0013
300 PRURITUS GENITAL 3 0.0013
301 HYPERLIPIDAEMIA 15 0.0013
302 OESOPHAGEAL CANDIDIASIS 5 0.0013
303 CUSHINGOID 4 0.0012
304 LOOSE TOOTH 4 0.0012
305 LIVER ABSCESS 4 0.0012
306 SPINAL FUSION SURGERY 5 0.0012
307 VENTRICULAR SEPTAL DEFECT 7 0.0012
308 PENIS DISORDER 3 0.0012
309 VENTRICULAR HYPERTROPHY 3 0.0012
310 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
311 ABORTION SPONTANEOUS 47 0.0012
312 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
313 DYSPHEMIA 5 0.0011
314 MENISCUS INJURY 7 0.0011
315 LOW BIRTH WEIGHT BABY 9 0.0011
316 WHEELCHAIR USER 5 0.0011
317 BLOOD PHOSPHORUS INCREASED 3 0.0011
318 AMYLASE INCREASED 4 0.0011
319 SYNOVIAL CYST 5 0.0011
320 FOETAL EXPOSURE DURING PREGNANCY 88 0.0011
321 HYPERBILIRUBINAEMIA 11 0.0011
322 CORONAVIRUS INFECTION 7 0.0011
323 MOBILITY DECREASED 75 0.0010
324 OESOPHAGEAL ULCER 4 0.0010
325 TOOTH DISORDER 23 0.0010
326 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
327 NECK INJURY 3 0.0010
328 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
329 LUNG ADENOCARCINOMA 3 0.0010
330 MUSCLE HAEMORRHAGE 4 0.0010
331 PROSTATITIS 3 0.0010
332 EXPOSURE DURING PREGNANCY 61 0.0010
333 PRODUCT DOSE OMISSION IN ERROR 27 0.0010
334 TREATMENT NONCOMPLIANCE 52 0.0009
335 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
336 GOUT 17 0.0009
337 MUSCLE ATROPHY 12 0.0009
338 MUSCLE FATIGUE 4 0.0009
339 TONGUE DISCOMFORT 4 0.0009
340 ABSCESS LIMB 4 0.0009
341 ANAEMIA MACROCYTIC 2 0.0009
342 HIP SURGERY 5 0.0009
343 PYELONEPHRITIS 8 0.0009
344 SKIN LACERATION 10 0.0009
345 BACK INJURY 10 0.0009
346 ABNORMAL DREAMS 25 0.0009
347 ACCIDENT AT WORK 2 0.0009
348 APPETITE DISORDER 6 0.0009
349 NEPHRITIS 3 0.0009
350 HAEMARTHROSIS 8 0.0009
351 WRONG PRODUCT ADMINISTERED 6 0.0009
352 HEPATIC FUNCTION ABNORMAL 33 0.0009
353 URINE ABNORMALITY 4 0.0009
354 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
355 NEUROLOGICAL SYMPTOM 5 0.0009
356 GAIT DISTURBANCE 166 0.0009
357 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
358 HYPOPNOEA 3 0.0009
359 NEPHROGENIC ANAEMIA 4 0.0009
360 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
361 JOINT DISLOCATION 9 0.0009
362 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 7 0.0008
363 HORMONE LEVEL ABNORMAL 4 0.0008
364 KIDNEY INFECTION 16 0.0008
365 NASAL POLYPS 4 0.0008
366 HYPOPHOSPHATAEMIA 6 0.0008
367 TENDON RUPTURE 10 0.0008
368 HYDRONEPHROSIS 6 0.0008
369 PREMATURE BABY 24 0.0008
370 HEPATIC NECROSIS 3 0.0008
371 APPENDICITIS PERFORATED 2 0.0008
372 LOSS OF LIBIDO 7 0.0008
373 SPINAL CORD COMPRESSION 3 0.0008
374 HERPES SIMPLEX 5 0.0008
375 EPIGASTRIC DISCOMFORT 3 0.0008
376 WALKING AID USER 5 0.0008
377 PATENT DUCTUS ARTERIOSUS 3 0.0008
378 JOINT INJURY 16 0.0007
379 ALCOHOL ABUSE 2 0.0007
380 JOINT RANGE OF MOTION DECREASED 10 0.0007
381 PRODUCT RESIDUE PRESENT 4 0.0007
382 ERECTILE DYSFUNCTION 19 0.0007
383 BIPOLAR DISORDER 8 0.0007
384 HYDROCEPHALUS 4 0.0007
385 HICCUPS 6 0.0007
386 BLOOD TESTOSTERONE DECREASED 5 0.0007
387 LEG AMPUTATION 3 0.0007
388 INTESTINAL ISCHAEMIA 4 0.0007
389 LIVER DISORDER 32 0.0007
390 NECROSIS 4 0.0007
391 GAIT INABILITY 24 0.0007
392 ANAL HAEMORRHAGE 2 0.0007
393 SLEEP TERROR 3 0.0007
394 LIGAMENT SPRAIN 7 0.0007
395 PREMATURE LABOUR 4 0.0007
396 SHOULDER OPERATION 3 0.0007
397 IMPAIRED WORK ABILITY 15 0.0007
398 ARTHRITIS 55 0.0007
399 HEPATIC STEATOSIS 13 0.0007
400 SCIATICA 11 0.0007
401 MUSCULOSKELETAL DISORDER 13 0.0007
402 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 23 0.0007
403 ILEUS PARALYTIC 3 0.0007
404 URINARY TRACT DISORDER 3 0.0007
405 BLOOD CHOLESTEROL INCREASED 31 0.0007
406 NIGHTMARE 23 0.0007
407 NEUROPATHY PERIPHERAL 63 0.0007
408 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
409 HAEMOGLOBIN INCREASED 3 0.0007
410 HEPATOCELLULAR CARCINOMA 5 0.0007
411 INSURANCE ISSUE 10 0.0007
412 PROCEDURAL COMPLICATION 5 0.0007
413 LIVER FUNCTION TEST INCREASED 14 0.0007
414 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
415 PRODUCT DISTRIBUTION ISSUE 6 0.0006
416 HAEMATURIA 22 0.0006
417 SWELLING OF EYELID 4 0.0006
418 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
419 MULTIPLE INJURIES 4 0.0006
420 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
421 SPINAL DISORDER 6 0.0006
422 WEIGHT INCREASED 141 0.0006
423 HALLUCINATION, AUDITORY 10 0.0006
424 LIMB INJURY 17 0.0006
425 MALNUTRITION 7 0.0006
426 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
427 ORAL HERPES 12 0.0006
428 PANCREATIC DISORDER 3 0.0006
429 INABILITY TO AFFORD MEDICATION 6 0.0006
430 THERAPY CESSATION 31 0.0006
431 SKIN MASS 4 0.0006
432 HYPERKALAEMIA 21 0.0006
433 ANXIETY DISORDER 2 0.0006
434 LIVE BIRTH 5 0.0006
435 TOXIC ENCEPHALOPATHY 3 0.0006
436 APPLICATION SITE DRYNESS 2 0.0006
437 FACIAL PARALYSIS 5 0.0006
438 VITAMIN D DECREASED 5 0.0006
439 PRODUCT COLOUR ISSUE 3 0.0006
440 SKIN HYPERPIGMENTATION 5 0.0006
441 TEMPERATURE INTOLERANCE 6 0.0006
442 DROOLING 4 0.0006
443 LARGE INTESTINE POLYP 4 0.0006
444 FOLLICULITIS 6 0.0006
445 PRODUCT USE COMPLAINT 9 0.0006
446 KNEE ARTHROPLASTY 12 0.0006
447 EATING DISORDER 12 0.0006
448 FOOD POISONING 3 0.0006
449 PARALYSIS 8 0.0006
450 GINGIVITIS 3 0.0006
451 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
452 OSTEOMYELITIS 10 0.0006
453 BACK PAIN 128 0.0006
454 ARTHRALGIA 228 0.0005
455 GASTROENTERITIS 8 0.0005
456 PRODUCT DOSE OMISSION ISSUE 161 0.0005
457 ACUTE MYOCARDIAL INFARCTION 16 0.0005
458 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
459 HYPERTENSIVE CRISIS 6 0.0005
460 SUICIDAL IDEATION 49 0.0005
461 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
462 ABORTION INDUCED 5 0.0005
463 LIVER INJURY 13 0.0005
464 FEAR 14 0.0005
465 AFFECT LABILITY 5 0.0005
466 BLOOD URIC ACID INCREASED 3 0.0005
467 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
468 CONGENITAL ANOMALY 4 0.0005
469 DIZZINESS POSTURAL 5 0.0005
470 HYPERTENSION 109 0.0005
471 NERVOUS SYSTEM DISORDER 16 0.0005
472 PERIPHERAL COLDNESS 7 0.0005
473 DECREASED INTEREST 3 0.0005
474 FRUSTRATION TOLERANCE DECREASED 4 0.0005
475 SEASONAL ALLERGY 7 0.0005
476 NOCTURIA 6 0.0005
477 INGUINAL HERNIA 3 0.0005
478 DRUG LEVEL DECREASED 5 0.0005
479 SLUGGISHNESS 5 0.0005
480 PANCREATITIS ACUTE 11 0.0005
481 CHROMATURIA 11 0.0005
482 SPINAL OPERATION 6 0.0005
483 PIGMENTATION DISORDER 3 0.0005
484 JAUNDICE 13 0.0005
485 MIDDLE INSOMNIA 9 0.0005
486 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
487 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
488 DYSPHAGIA 45 0.0005
489 PANCREATITIS 25 0.0005
490 ALCOHOLISM 2 0.0005
491 PROCTALGIA 3 0.0005
492 NIGHT SWEATS 15 0.0005
493 ABNORMAL SENSATION IN EYE 2 0.0005
494 MUSCLE STRAIN 4 0.0005
495 DYSURIA 17 0.0005
496 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
497 PRODUCT PREPARATION ISSUE 3 0.0005
498 ANAEMIA 87 0.0005
499 ORAL CANDIDIASIS 6 0.0005
500 GRIP STRENGTH DECREASED 4 0.0005
501 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
502 GASTROOESOPHAGEAL REFLUX DISEASE 36 0.0004
503 DIABETES MELLITUS 34 0.0004
504 BRONCHIECTASIS 3 0.0004
505 OBESITY 7 0.0004
506 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
507 ACUTE HEPATIC FAILURE 6 0.0004
508 ABDOMINAL HERNIA 2 0.0004
509 TINNITUS 20 0.0004
510 RESPIRATION ABNORMAL 3 0.0004
511 IRON DEFICIENCY ANAEMIA 4 0.0004
512 ARTHROPATHY 24 0.0004
513 HEPATIC ENCEPHALOPATHY 4 0.0004
514 CARPAL TUNNEL SYNDROME 6 0.0004
515 INSOMNIA 114 0.0004
516 SPINAL PAIN 5 0.0004
517 SEXUAL DYSFUNCTION 5 0.0004
518 MANIA 7 0.0004
519 GASTROINTESTINAL DISORDER 38 0.0004
520 BLOOD URINE PRESENT 8 0.0004
521 CYTOMEGALOVIRUS INFECTION 7 0.0004
522 PRODUCT PACKAGING ISSUE 4 0.0004
523 JOINT STIFFNESS 11 0.0004
524 POOR QUALITY SLEEP 9 0.0004
525 PARAESTHESIA ORAL 6 0.0004
526 PANIC REACTION 3 0.0004
527 DERMATITIS BULLOUS 3 0.0004
528 HYPERCHOLESTEROLAEMIA 4 0.0004
529 HERNIA 8 0.0004
530 PRODUCT DOSE OMISSION 27 0.0004
531 PANIC ATTACK 15 0.0004
532 NEURALGIA 10 0.0004
533 MAJOR DEPRESSION 3 0.0004
534 RHABDOMYOLYSIS 17 0.0004
535 THERAPY CHANGE 4 0.0004
536 KNEE OPERATION 4 0.0004
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
538 HYPERCALCAEMIA 5 0.0004
539 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
540 CYST 5 0.0004
541 LACTIC ACIDOSIS 13 0.0004
542 SALIVARY HYPERSECRETION 4 0.0004
543 DEPRESSED MOOD 21 0.0004
544 PRODUCT PHYSICAL ISSUE 8 0.0004
545 GALLBLADDER DISORDER 7 0.0004
546 MENTAL DISORDER 17 0.0004
547 HOSPITALISATION 60 0.0004
548 INJECTION SITE INDURATION 5 0.0004
549 AFFECTIVE DISORDER 3 0.0004
550 RENAL CANCER 18 0.0004
551 PREMATURE DELIVERY 6 0.0004
552 ANAL FISTULA 2 0.0004
553 SENSORY LOSS 3 0.0004
554 RHINITIS 3 0.0004
555 MYASTHENIA GRAVIS 3 0.0004
556 ANAL ABSCESS 2 0.0004
557 SUBSTANCE ABUSE 3 0.0004
558 FEELING JITTERY 7 0.0004
559 PRODUCT USE ISSUE 69 0.0004
560 IMPAIRED GASTRIC EMPTYING 5 0.0004
561 ABNORMAL FAECES 3 0.0004
562 HEPATIC FAILURE 11 0.0004
563 APHASIA 11 0.0004
564 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
565 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
566 ASTHENIA 136 0.0004
567 NERVE INJURY 4 0.0004
568 HAEMODIALYSIS 3 0.0004
569 TYPE 2 DIABETES MELLITUS 12 0.0004
570 NEPHROPATHY TOXIC 4 0.0004
571 SENSATION OF FOREIGN BODY 3 0.0004
572 HAEMATEMESIS 9 0.0004
573 DISABILITY 7 0.0004
574 DERMATITIS CONTACT 4 0.0004
575 MICTURITION URGENCY 4 0.0003
576 PRODUCT CONTAINER ISSUE 3 0.0003
577 GASTRIC DISORDER 12 0.0003
578 MUSCULOSKELETAL DISCOMFORT 6 0.0003
579 GENERAL PHYSICAL HEALTH DETERIORATION 40 0.0003
580 DYSPEPSIA 34 0.0003
581 HYPERTHYROIDISM 5 0.0003
582 FEEDING DISORDER 7 0.0003
583 PARAESTHESIA 54 0.0003
584 BLOOD CALCIUM INCREASED 3 0.0003
585 GASTRITIS 9 0.0003
586 FATIGUE 265 0.0003
587 BLOOD IRON DECREASED 4 0.0003
588 ATAXIA 4 0.0003
589 GASTROINTESTINAL INFECTION 3 0.0003
590 POLYNEUROPATHY 4 0.0003
591 TOOTHACHE 6 0.0003
592 RETCHING 7 0.0003
593 CEREBRAL INFARCTION 8 0.0003
594 ABDOMINAL DISTENSION 34 0.0003
595 MUSCULAR WEAKNESS 37 0.0003
596 ANGER 11 0.0003
597 HYPOKALAEMIA 15 0.0003
598 HEPATIC ENZYME INCREASED 22 0.0003
599 PHARYNGITIS 4 0.0003
600 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
601 HEPATIC CIRRHOSIS 6 0.0003
602 BRAIN OEDEMA 4 0.0003
603 RECALLED PRODUCT ADMINISTERED 3 0.0003
604 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
605 GLAUCOMA 6 0.0003
606 LYMPHADENOPATHY 11 0.0003
607 ILLNESS 32 0.0003
608 ERUCTATION 6 0.0003
609 THERAPY INTERRUPTED 22 0.0003
610 HEPATOMEGALY 3 0.0003
611 ABDOMINAL DISCOMFORT 51 0.0003
612 STAPHYLOCOCCAL INFECTION 10 0.0003
613 DRUG INTERACTION 48 0.0003
614 NAUSEA 239 0.0003
615 MYALGIA 51 0.0003
616 BRAIN INJURY 3 0.0003
617 EMPHYSEMA 3 0.0003
618 PRODUCT ADMINISTRATION ERROR 6 0.0003
619 SUICIDE ATTEMPT 18 0.0003
620 SINUS CONGESTION 4 0.0003
621 HYPOAESTHESIA 44 0.0003
622 GINGIVAL BLEEDING 4 0.0003
623 EUPHORIC MOOD 3 0.0003
624 HELICOBACTER INFECTION 3 0.0003
625 SWELLING FACE 19 0.0003
626 SURGERY 17 0.0003
627 TENDERNESS 3 0.0003
628 ECZEMA 15 0.0003
629 ABDOMINAL PAIN UPPER 59 0.0003
630 DERMATITIS 6 0.0003
631 MUSCULOSKELETAL PAIN 15 0.0003
632 NECK PAIN 16 0.0003
633 NEUROTOXICITY 5 0.0003
634 INCONTINENCE 3 0.0003
635 HEAD DISCOMFORT 5 0.0003
636 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
637 WEIGHT DECREASED 77 0.0003
638 CHOLELITHIASIS 9 0.0003
639 HYPERGLYCAEMIA 10 0.0003
640 DEATH 235 0.0003
641 INJECTION SITE NODULE 3 0.0003
642 PAIN IN EXTREMITY 80 0.0003
643 FOOT DEFORMITY 3 0.0003
644 INJECTION SITE MASS 10 0.0003
645 SNEEZING 6 0.0003
646 BLOOD CALCIUM DECREASED 3 0.0003
647 STATUS EPILEPTICUS 3 0.0003
648 HEART RATE IRREGULAR 6 0.0003
649 DERMATITIS ATOPIC 14 0.0003
650 REBOUND EFFECT 3 0.0003
651 DRUG DISPENSING ERROR 4 0.0003
652 INCREASED APPETITE 5 0.0003
653 RASH 114 0.0003
654 SEIZURE 30 0.0003
655 MUSCULOSKELETAL CHEST PAIN 4 0.0003
656 TENDONITIS 4 0.0003
657 BACTERAEMIA 3 0.0003
658 DISEASE RECURRENCE 12 0.0003
659 MYOCLONUS 3 0.0003
660 ULCER 4 0.0003
661 ACCIDENT 3 0.0003
662 DEMENTIA 7 0.0003
663 FEELING ABNORMAL 60 0.0003
664 BURSITIS 3 0.0002
665 SCHIZOPHRENIA 3 0.0002
666 BACK DISORDER 4 0.0002
667 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
668 HEADACHE 153 0.0002
669 DIARRHOEA 156 0.0002
670 DISTURBANCE IN ATTENTION 13 0.0002
671 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
672 MIGRAINE 23 0.0002
673 SLEEP DISORDER 17 0.0002
674 VOMITING 113 0.0002
675 COAGULOPATHY 4 0.0002
676 SKIN DISORDER 8 0.0002
677 SKIN DISCOLOURATION 11 0.0002
678 PALPITATIONS 28 0.0002
679 DERMATITIS ALLERGIC 3 0.0002
680 HALLUCINATION, VISUAL 5 0.0002
681 CARDIOVASCULAR DISORDER 6 0.0002
682 COVID-19 41 0.0002
683 ROTATOR CUFF SYNDROME 3 0.0002
684 INFUSION SITE PAIN 3 0.0002
685 ILL-DEFINED DISORDER 14 0.0002
686 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
687 PRODUCT PRESCRIBING ISSUE 5 0.0002
688 BLOOD GLUCOSE INCREASED 43 0.0002
689 INJURY 16 0.0002
690 TOOTH INFECTION 3 0.0002
691 SARS-COV-2 TEST POSITIVE 3 0.0002
692 DYSMENORRHOEA 3 0.0002
693 DRUG ERUPTION 4 0.0002
694 HALLUCINATION 17 0.0002
695 STEVENS-JOHNSON SYNDROME 5 0.0002
696 CARDIAC DISORDER 21 0.0002
697 THIRST 4 0.0002
698 RASH PAPULAR 5 0.0002
699 ANAL INCONTINENCE 2 0.0002
700 BLOOD BILIRUBIN INCREASED 6 0.0002
701 HEAD INJURY 7 0.0002
702 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
703 RESTLESSNESS 8 0.0002
704 CEREBROVASCULAR ACCIDENT 37 0.0002
705 PERICARDIAL EFFUSION 5 0.0002
706 BRONCHITIS 16 0.0002
707 HUNGER 3 0.0002
708 PERIPHERAL SWELLING 33 0.0002
709 BLOOD TEST ABNORMAL 3 0.0002
710 VERTIGO 13 0.0002
711 IMPAIRED HEALING 7 0.0002
712 INFLAMMATION 11 0.0002
713 LYMPHOPENIA 3 0.0002
714 PAIN IN JAW 6 0.0002
715 FLATULENCE 12 0.0002
716 ARRHYTHMIA 10 0.0002
717 GASTRIC ULCER 4 0.0002
718 SLEEP APNOEA SYNDROME 4 0.0002
719 DRY MOUTH 17 0.0002
720 ANGINA PECTORIS 6 0.0002
721 HYPERSOMNIA 6 0.0002
722 EAR PAIN 4 0.0002
723 TREATMENT FAILURE 17 0.0002
724 RASH PRURITIC 11 0.0002
725 OEDEMA 11 0.0002
726 URINARY INCONTINENCE 6 0.0002
727 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
728 BLOOD PRESSURE ABNORMAL 4 0.0002
729 HAEMORRHAGE 21 0.0002
730 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
731 PNEUMONIA ASPIRATION 5 0.0002
732 LEUKOPENIA 10 0.0002
733 AMNESIA 13 0.0002
734 HAEMATOCHEZIA 11 0.0002
735 ACNE 15 0.0002
736 SEPSIS 22 0.0002
737 PANCYTOPENIA 11 0.0002
738 BLINDNESS 8 0.0002
739 EPILEPSY 6 0.0002
740 HYPOPHAGIA 5 0.0002
741 DEHYDRATION 26 0.0002
742 DIZZINESS 97 0.0002
743 PULMONARY HYPERTENSION 4 0.0002
744 HERPES ZOSTER 11 0.0002
745 ACCIDENTAL OVERDOSE 7 0.0002
746 DRUG-INDUCED LIVER INJURY 6 0.0002
747 ROAD TRAFFIC ACCIDENT 8 0.0002
748 MOOD SWINGS 6 0.0002
749 CONSTIPATION 41 0.0002
750 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
751 CONTUSION 18 0.0002
752 BLOOD POTASSIUM INCREASED 3 0.0002
753 FAECES DISCOLOURED 4 0.0002
754 OFF LABEL USE 161 0.0002
755 CHEST PAIN 34 0.0002
756 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
757 SKIN LESION 5 0.0002
758 PHOTOSENSITIVITY REACTION 3 0.0002
759 VISUAL ACUITY REDUCED 6 0.0002
760 DISCOMFORT 11 0.0002
761 LIP SWELLING 6 0.0002
762 MEDICATION ERROR 10 0.0002
763 MUSCLE SPASMS 33 0.0002
764 NEOPLASM MALIGNANT 12 0.0002
765 HAEMOPTYSIS 5 0.0002
766 BLOOD UREA INCREASED 3 0.0002
767 WOUND 5 0.0002
768 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
769 PRURITUS 68 0.0002
770 CIRCULATORY COLLAPSE 3 0.0002
771 CONDITION AGGRAVATED 53 0.0002
772 PARANOIA 3 0.0002
773 LETHARGY 10 0.0002
774 BALANCE DISORDER 15 0.0002
775 MUSCLE TWITCHING 4 0.0002
776 HOT FLUSH 13 0.0002
777 HYPERSENSITIVITY 32 0.0002
778 ABDOMINAL PAIN 40 0.0002
779 UNEVALUABLE EVENT 13 0.0002
780 NEUTROPHIL COUNT DECREASED 7 0.0002
781 MUSCULOSKELETAL STIFFNESS 15 0.0002
782 LABORATORY TEST ABNORMAL 5 0.0002
783 PSYCHOTIC DISORDER 5 0.0002
784 CEREBRAL HAEMORRHAGE 6 0.0002
785 MEMORY IMPAIRMENT 23 0.0002
786 MALAISE 73 0.0002
787 IRRITABILITY 10 0.0002
788 SKIN EXFOLIATION 14 0.0002
789 PELVIC PAIN 3 0.0002
790 MENTAL IMPAIRMENT 4 0.0002
791 RESTLESS LEGS SYNDROME 3 0.0002
792 ADRENAL INSUFFICIENCY 2 0.0002
793 AGITATION 12 0.0002
794 ENCEPHALOPATHY 4 0.0002
795 ABNORMAL WEIGHT GAIN 2 0.0002
796 PYREXIA 56 0.0002
797 DYSGEUSIA 12 0.0002
798 THINKING ABNORMAL 3 0.0002
799 BACTERIAL INFECTION 3 0.0002
800 SWELLING 15 0.0002
801 SYNCOPE 16 0.0002
802 EYE PAIN 9 0.0002
803 FALL 53 0.0002
804 CELLULITIS 8 0.0002
805 INFLUENZA LIKE ILLNESS 13 0.0002
806 PRODUCT COMPLAINT 4 0.0002
807 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
808 BURNING SENSATION 11 0.0002
809 PRODUCT SUBSTITUTION ISSUE 9 0.0002
810 DRUG ABUSE 13 0.0002
811 ACUTE RESPIRATORY FAILURE 3 0.0002
812 DECREASED APPETITE 36 0.0002
813 DYSTONIA 3 0.0002
814 RASH GENERALISED 4 0.0002
815 HAEMORRHOIDS 3 0.0002
816 DEAFNESS 4 0.0002
817 THROMBOCYTOPENIA 17 0.0002
818 ANKYLOSING SPONDYLITIS 2 0.0002
819 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
820 DRUG DOSE OMISSION 25 0.0002
821 EXPIRED PRODUCT ADMINISTERED 5 0.0002
822 PRESCRIBED UNDERDOSE 3 0.0002
823 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
824 THROMBOSIS 12 0.0001
825 SOMNOLENCE 30 0.0001
826 INTENTIONAL PRODUCT MISUSE 13 0.0001
827 THROAT TIGHTNESS 4 0.0001
828 DYSKINESIA 6 0.0001
829 OCULAR HYPERAEMIA 7 0.0001
830 INJURY ASSOCIATED WITH DEVICE 3 0.0001
831 TACHYCARDIA 13 0.0001
832 PRODUCT PREPARATION ERROR 3 0.0001
833 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
834 INFLUENZA 16 0.0001
835 APHONIA 2 0.0001
836 RASH MACULAR 5 0.0001
837 ALOPECIA 28 0.0001
838 HYPOXIA 5 0.0001
839 HEART RATE INCREASED 14 0.0001
840 RED BLOOD CELL COUNT DECREASED 4 0.0001
841 RECTAL HAEMORRHAGE 6 0.0001
842 PRURITUS GENERALISED 3 0.0001
843 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
844 ANOSMIA 2 0.0001
845 CRYING 5 0.0001
846 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
847 APATHY 2 0.0001
848 MELAENA 3 0.0001
849 CONFUSIONAL STATE 22 0.0001
850 HEPATOTOXICITY 3 0.0001
851 DRUG INTOLERANCE 13 0.0001
852 EYE SWELLING 5 0.0001
853 EPISTAXIS 10 0.0001
854 ADVERSE DRUG REACTION 12 0.0001
855 SPEECH DISORDER 7 0.0001
856 ATRIAL FIBRILLATION 13 0.0001
857 DYSARTHRIA 5 0.0001
858 INTESTINAL OBSTRUCTION 5 0.0001
859 HYPERHIDROSIS 17 0.0001
860 THERAPEUTIC RESPONSE DECREASED 8 0.0001
861 PRODUCT AVAILABILITY ISSUE 3 0.0001
862 EMOTIONAL DISORDER 4 0.0001
863 LIMB DISCOMFORT 4 0.0001
864 DISORIENTATION 5 0.0001
865 INJECTION SITE BRUISING 10 0.0001
866 LOSS OF CONSCIOUSNESS 16 0.0001
867 HYPONATRAEMIA 7 0.0001
868 HYPOGLYCAEMIA 6 0.0001
869 EXTRA DOSE ADMINISTERED 5 0.0001
870 PSORIATIC ARTHROPATHY 5 0.0001
871 INJECTION SITE URTICARIA 3 0.0001
872 EYE DISORDER 4 0.0001
873 CARDIAC ARREST 10 0.0001
874 MYOCARDIAL INFARCTION 21 0.0001
875 AGEUSIA 3 0.0001
876 INFECTION 17 0.0001
877 INJECTION SITE PAIN 36 0.0001
878 SINUSITIS 12 0.0001
879 DYSPNOEA 66 0.0001
880 SKIN ULCER 3 0.0001
881 DIPLOPIA 3 0.0001
882 STOMATITIS 7 0.0001
883 DRUG INEFFECTIVE 152 0.0001
884 RESPIRATORY TRACT INFECTION 3 0.0001
885 URTICARIA 19 0.0001
886 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
887 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
888 PNEUMONIA 36 0.0001
889 CHILLS 13 0.0001
890 COUGH 31 0.0001
891 PALLOR 3 0.0001
892 VISION BLURRED 15 0.0001
893 TREMOR 18 0.0001
894 DIVERTICULITIS 3 0.0001
895 MENTAL STATUS CHANGES 3 0.0001
896 FEELING COLD 3 0.0001
897 DEEP VEIN THROMBOSIS 7 0.0001
898 COGNITIVE DISORDER 5 0.0001
899 BLISTER 6 0.0001
900 OEDEMA PERIPHERAL 13 0.0001
901 TARDIVE DYSKINESIA 3 0.0001
902 DYSPNOEA EXERTIONAL 4 0.0001
903 BLOOD PRESSURE DECREASED 7 0.0001
904 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
905 INCORRECT DOSE ADMINISTERED 24 0.0001
906 PRODUCTIVE COUGH 5 0.0001
907 RASH ERYTHEMATOUS 5 0.0001
908 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
909 LIVER FUNCTION TEST ABNORMAL 3 0.0001
910 NASOPHARYNGITIS 19 0.0001
911 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
912 ASCITES 3 0.0001
913 ABNORMAL BEHAVIOUR 4 0.0001
914 AGGRESSION 5 0.0001
915 JOINT SWELLING 12 0.0001
916 LACRIMATION INCREASED 3 0.0001
917 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
918 FLUID RETENTION 5 0.0001
919 BLOOD PRESSURE INCREASED 15 0.0001
920 LUNG NEOPLASM MALIGNANT 4 0.0001
921 GYNAECOMASTIA 3 0.0001
922 INJECTION SITE ERYTHEMA 12 0.0001
923 RESPIRATORY FAILURE 7 0.0001
924 NEUTROPENIA 13 0.0001
925 MOVEMENT DISORDER 3 0.0001
926 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
927 PSORIASIS 12 0.0001
928 APPLICATION SITE PAIN 2 0.0001
929 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
930 ANGIOEDEMA 4 0.0001
931 FUNGAL INFECTION 3 0.0001
932 INJECTION SITE PRURITUS 6 0.0001
933 EYE PRURITUS 3 0.0001
934 OXYGEN SATURATION DECREASED 5 0.0001
935 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
936 ASTHMA 10 0.0001
937 SKIN IRRITATION 4 0.0001
938 PROSTATE CANCER 7 0.0001
939 EYE IRRITATION 5 0.0001
940 ADVERSE EVENT 8 0.0001
941 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
942 HEART RATE DECREASED 3 0.0001
943 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
944 PLATELET COUNT DECREASED 9 0.0001
945 SKIN BURNING SENSATION 6 0.0001
946 ERYTHEMA 17 0.0001
947 DRUG EFFECT INCOMPLETE 3 0.0001
948 URINARY TRACT INFECTION 14 0.0001
949 COLITIS 3 0.0001
950 ABDOMINAL PAIN LOWER 2 0.0001
951 FLUSHING 8 0.0001
952 INJECTION SITE SWELLING 6 0.0001
953 INTENTIONAL OVERDOSE 5 0.0001
954 NERVOUSNESS 4 0.0001
955 OROPHARYNGEAL PAIN 7 0.0001
956 DRY SKIN 10 0.0001
957 VISUAL IMPAIRMENT 9 0.0001
958 WITHDRAWAL SYNDROME 3 0.0001
959 HYPOACUSIS 3 0.0001
960 DYSPHONIA 4 0.0001
961 CHEST DISCOMFORT 7 0.0001
962 HAEMOGLOBIN DECREASED 7 0.0001
963 CATARACT 4 0.0001
964 THERAPY NON-RESPONDER 3 0.0001
965 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
966 MULTIPLE SCLEROSIS 3 0.0001
967 INJECTION SITE HAEMORRHAGE 5 0.0001
968 CARDIAC FAILURE CONGESTIVE 5 0.0001
969 TOXICITY TO VARIOUS AGENTS 10 0.0001
970 INJECTION SITE REACTION 4 0.0001
971 ANAPHYLACTIC REACTION 3 0.0001
972 FEELING HOT 3 0.0000
973 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
974 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
975 RHINORRHOEA 3 0.0000
976 OVERDOSE 10 0.0000
977 PRODUCT QUALITY ISSUE 6 0.0000
978 NO ADVERSE EVENT 8 0.0000
979 BREAST CANCER 4 0.0000
980 PULMONARY EMBOLISM 4 0.0000
981 UNDERDOSE 3 0.0000
982 CARDIAC FAILURE 3 0.0000
983 DRUG DEPENDENCE 6 0.0000
984 COMPLETED SUICIDE 3 0.0000
985 RHEUMATOID ARTHRITIS 4 0.0000
986 HYPOTENSION 7 0.0000
987 DISEASE PROGRESSION 4 0.0000